Bone Biologics Corp. (BBLG)

Last Closing Price: 0.18 (2023-06-02)

Company Description

Bone Biologics Corp. is a developer of orthobiologic products for spine fusion markets. Bone Biologics Corp. is based in BURLINGTON, Mass.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) --
Net Income (Most Recent Fiscal Year) $-1.49M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.11
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -96.34%
Return on Assets (Trailing 12 Months) -68.95%
Current Ratio (Most Recent Fiscal Quarter) 1.69
Quick Ratio (Most Recent Fiscal Quarter) 1.69
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) --
Book Value per Share (Most Recent Fiscal Quarter) $0.39
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) --
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Common Shares Outstanding 16.70M
Free Float 9.57M
Market Capitalization $3.07M
Average Volume (Last 20 Days) 1.40M
Beta (Past 60 Months) 0.76
Percentage Held By Insiders (Latest Annual Proxy Report) 42.70%
Percentage Held By Institutions (Latest 13F Reports) 7.56%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%